Funds and ETFs Procaps Group S.A.

Equities

PROC

LU2376511205

Pharmaceuticals

Market Closed - Nasdaq 02:00:00 26/04/2024 am IST 5-day change 1st Jan Change
2.727 USD -0.83% Intraday chart for Procaps Group S.A. +0.63% -33.00%

ETFs positioned on Procaps Group S.A.

Name Weight AuM 1st Jan change Investor Rating
0.00% 117 M€ +1.11% -
Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
2.727 USD
Average target price
4.75 USD
Spread / Average Target
+74.18%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. PROC Stock
  4. Funds and ETFs Procaps Group S.A.